HIV/AIDS Information Center Archive
Risk greatest with higher-dose opioids and opioids with immunosuppressive properties.
Depression is a common comorbidity in people living with HIV, with lifetime prevalence estimates ranging from 22% to 61%.
Investigators sought to determine the association between liver fibrosis and hepatitis B virus genotype G in patients with comorbid HIV and HBV.
HIV-exposed infants have high rates of congenital cCMV infection, and in utero HIV infection seems to be a major risk factor for cCMV.
HIV-infected Hispanics have an increased risk for human papillomavirus-related cancers than Hispanics in the general population.
Family-centered pediatric advance care planning is associated with a lower likelihood of symptoms and suffering for adolescents with HIV.
Seven percent of those with indications for PrEP were prescribed PrEP, including 2.1% of women.
Analysis of 2 phase 3 clinical trials evaluating the safety/efficacy of glecaprevir/pibrentasvir in people with HCV coinfected with HIV-1 found an overall sustained virologic response of 98% at week 12 of treatment in those with or without cirrhosis.
A combination single tablet once-a-day regimen of doravirine/lamivudine/tenofovir disoproxil fumarate demonstrated non-inferiority and no significant adverse events when compared with continuation of established antiretroviral therapy in adults infected with HIV-1.
Number of HIV diagnoses in those aged 13 to 29 4x higher than those aged 50 years.
Inspection at the VIP Spa in Albuquerque detected practices that might spread HIV or hepatitis B and C.
Delstrigo is approved as a complete regimen whereas Pifeltro is to be administered in combination with other antiretrovirals.
Compared with uninfected individuals, people with HIV controlled with combination antiretroviral therapy are not at increased risk of developing thyroid dysfunction.
Patient navigation may be considered an effective strategy to enhance engagement and continuation in disease treatment among people with HIV.
Lower odds of having detectable viral load for older adults and those using ISTI-based regimen.
Lower degree of susceptibility to ibalizumab for 9 of 10 patients with virology failure, rebound.
The International Antiviral Society-USA Panel has updated its recommendations for the management and prevention of HIV infection, to reflect the most current data on new treatment regimens and strategies.
Intervention group had greater reduction in condomless sex acts vs standard of care group.
Close to one-third of sexually active HIV-positive men who have sex with men (MSM) have not received syphilis screening in the past 12 months.
Findings among teens diagnosed with pelvic inflammatory disease in the emergency department.
ART recommended for almost all HIV-infected; should be initiated as soon as possible post diagnosis.
Investigators added hepatitis C virus and HIV screening tests to standard trauma activation laboratory orders.
Vaccinated women and girls living with HIV may be at greater risk for HPV vaccine failure compared with women and girls without HIV.
Single high-dose liposomal amphotericin B (L-AmB) is non-inferior to daily dosed L-AmB at the standard dose in treatment of fungal clearance in HIV-associated cryptococcal meningitis.
Cirrhosis is associated with an increased risk for diabetes mellitus among patients living with HIV.
No increased risk of depression or suicidal ideation among persons living with HIV in Uganda.
Annual occasion is a good time for health care providers to encourage testing
The Agency has received reports of serious neural tube birth defects involving the brain, spine, and spinal cord in babies born to women who received dolutegravir for HIV treatment.
CVS Health faces lawsuit for revealing the HIV status of 6,000 patients in Ohio.
The FDA has approved Trogarzo for heavily treated adult patients living with HIV and whose HIV infections cannot be successfully treated with other currently available therapies.
Recommendations for daily doses of emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) resulted in protective drug concentrations for men and transgender women.
The two most prevalent HIV symptoms, fatigue and muscle aches, are more common in women than men and can worsen with menopause.
A new antiretroviral HIV treatment, Trogarzo (ibalizumab-uiyk), has been approved by the FDA for patients with HIV who have not have success with past HIV medications.
Increasing awareness of and access to newer HIV testing options such as free or reduced price on home and self-tests and couples HIV testing and counseling can facilitate increased levels of consistent testing among young, Black MSM, and transgender women.
Bacterial vaginosis may cause an increased risk for HIV acquisition in women taking oral or injectable hormonal contraception.
Excessive alcohol consumption does not impact the decline of CD4 cell count in patients with HIV who have not undergone antiretroviral treatments.
Chronicity of depression is associated with increased likelihood of failure along the continuum of HIV care.
For young adults without known risk factors, a one-time routine HIV screen at 25 years would optimize clinical outcomes and be cost-effective.
Post-seroconversion brain morphology can occur in HIV patients, but aviremia maintenance via cART can slow of prevent brain injuries.
A new report from the CDC finds that HIV is being diagnosed sooner after initial infection than in previous years.
Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir.
The decrease in HIV incidence in Uganda was facilitated by antiretroviral therapy, male circumcision, and adolescent abstinence.
More tests might be administered to transgender individuals who are female, black, or sex workers.
The dual combination of dolutegravir plus darunavir/ritonavir provided a simple and safe salvage therapy to suppress viral replication without metabolic impact in patients infected with HIV-1.
Hepatitis B and hepatitis C may increase mortality risks in HIV patients.
The Ohio Supreme Court has unanimously upheld the constitutionality of a law requiring HIV-infected individuals to tell their sexual partners of their illness.
The CDC revised its US Medical Eligibility Criteria for Contraceptive Use categorization for DMPA injection in women at high risk for HIV infection from US MEC category 1 to US MEC category 2.
Resistance to ART is threatening the recent gains of treatment in the rate of new HIV infections.
More than half of women receiving a new HIV diagnosis have already received this diagnosis in the past but are not undergoing HIV medical care.
Infection was diagnosed at an early stage for fewer males with infection attributed to heterosexual contact vs male-to-male sexual contact.
The HIV Medicine Association of the Infectious Disease Society of America recommends that people living with HIV be screened for pain and offered both nonpharmacologic and pharmacologic treatment options.
Virological response, efficacy, noninferiority, and tolerability were tested for bictegravir, emtricitabine, and tenofovir alafenamide in patients with HIV.
In 16 countries, notification rates for new HIV diagnoses in older adults increased significantly, clustering in central and eastern European countries.
Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide was well tolerated in children and maintained high virological suppression.
High-dose vitamin D supplements improve bone mineral density in youth with HIV.
Alternative treatments should be offered to pregnant women with HIV instead of tenofovir or emtricitabine.
Smartphone-based electronic reader reliable for point-of-care tests in HIV and T pallidum infections
The findings shed new light on the applicability of smartphone-based electronic readers in point-of-care testing.
Adherence decreased over time in adolescent MSM who participated in a 48-week HIV PrEP intervention.
Women with mental illness engage in significantly more sexually risky behaviors than men, and personality risk scores are a significant predictor of total sex acts for women but not men.
Rapid HIV testing offered in parallel to patient-clinician consultations increases the testing rate in the emergency department.
The new guidelines address the issue of how to manage pretreatment HIV drug resistance in countries where the prevalence of is 10% or higher.
A child who was diagnosed with HIV at 1 month and received early treatment has suppressed the virus without anti-HIV therapy for 8.5 years.
The investigators found that after 32 weeks, HIV remained suppressed in 91% percent of those taking the drugs orally, 94% of those receiving monthly injections, and 95% of patients receiving injections every two months.
HIV, hepatitis B, and hepatitis C infections are more common among individuals with severe mental illness.
The update includes 30 new medicines for adults and 25 for children and groups antibiotics into 3 distinct categories.
Early antiretroviral therapy initiation may increase the rate of bone loss in HIV patients.
Providers in 17 new Walgreens locations will be able to prescribe PrEP for HIV prevention.
The drug is indicated for use in combination with other antiretroviral agents for the treatment of pediatric and adult patients with HIV-1.
The CDC found that 28% of young men who have sex with men have undergone HIV testing, though they account for 83% of new diagnoses.
Hepatitis C treatment in HIV coinfection cases is effective with standardized nurse and pharmacist support for patients in an urban clinic.
Treatment with amphotericin B was superior to itraconazole as an induction therapy for HIV-associated talaromycosis.
Continued antiretroviral therapy was found to be safe and beneficial in HIV-positive postpartum women with high CD4+ T cell counts.
HIV-infected patients on ART had approximately 4 and 1.5 greater odds of developing diabetes mellitus and metabolic syndrome, respectively.
Factors linked to health-related quality of life in military HIV patients include advanced HIV disease and mental or medical comorbidity.
Strategies are available to reduce the risk of HIV transmission using sperm from HIV-infected male.
Researchers predict that the infection rate could be as low as 12,000 people a year by 2025.
Nitrate inhalants (poppers) associated with increased virus-associated cancer risk in HIV-uninfected MSM
Among HIV-uninfected men aged 50 to 70, heavy popper use was associated with an increased risk of virus-associated cancer with causes linked to HPV, HHV-8, and Epstein-Barr virus.
Results showed that mean induction times, analyzed in 170 patients, were 12.87 days in the HIV-infected patients and 11.19 days in the HIV-uninfected patients.
The FDA Drug Interactions section has been updated to include revised information on concomitant use of corticosteroids with these drugs.
Almost half of participants reported that they never received information regarding the side effects of their medication from their prescriber.
A World Health Organization expert panel recommended lay health care workers be allowed to conduct HIV testing services using rapid diagnostic tests.
However, missed opportunities for prevention were common among infected infants and their mothers in recent years.
The HIV-positive population of the United Kingdom has a higher risk of death than the general population, despite availability of free treatment and care.
A VA center in Wisconsin is advising veterans to be screened for hepatitis and HIV after receiving care from a dentist who did not follow VA procedures.
The study will be the largest HIV vaccine clinical trial to take place in South Africa.
The number of patients dying from infections has remained stable, but some disease threats have changed.
Antenatal ART reduces rates of early HIV transmission but may increase risk of adverse maternal and neonatal outcomes.
Men and women who quit smoking after entering HIV care at age 40 years gained 5.7 years and 4.6 years of life expectancy, respectively, compared with those who continued to smoke.
HIV-infected individuals should receive the meningococcal conjugate vaccine (serogroups A, C, W, and Y).
The study debunks the theory that Patient Zero was responsible for the AIDS epidemic in North America.
Speakers at IDWeek 2016 addressed the demand for additional HIV care providers.
Recent data suggest that use of depot medroxyprogesterone acetate may increase women's HIV acquisition risk.
Patients with HIV receiving antiretroviral treatment have a higher risk of non-Hodgkin's lymphoma with HBV and HCV coinfection.
Treatment with 3 medications compared with 4 or more correlated with immune success at the end of follow-up.
The results of a multicenter, cross-sectional study showed that 37% of patients could have been diagnosed with HIV at an earlier stage.
The efficacy and safety of ART have greatly improved with the newer drug classes of antiretrovirals.
Researchers analyzed data from 21 jurisdictions conducting HIV incidence surveillance from 2007 to 2013.
Patients with HIV infection with immediate access to antiretroviral therapy may have a reduced risk of infection-related cancer.
Free self-test kits were advertised among a population of high-risk MSM.
Researchers observed 78 HIV-1 among partners, with an annual incidence of 0.9%.